Legal Opinion

Ferring Pharm., Inc. v. Azar

Court of Appeals for the D.C. Circuit

Decided February 13, 2018No. Civil Action No.: 15–802 (RC)PublishedCited by 2 opinions

1Opinion of the Court

RUDOLPH CONTRERAS, United States District Judge

DENYING PLAINTIFF'S MOTION TO ENFORCE JUDGMENT

I. INTRODUCTION

This case returns to this Court one year after the grant of summary judgment to Plaintiff Ferring Pharmaceuticals, Inc. ("Ferring") due to Defendant U.S. Food and Drug Administration's ("the FDA") surprise change of position regarding the chemical classification of a molecule within Plaintiff's colon cleansing drug, Prepopik. For years, Ferring and the FDA have agreed that picosulfate is the active moiety2 within the molecule sodium picosulfate, *170one of the three active ingredients in…

2Cases cited29 opinions

  1. Chevron U. S. A. Inc. v. Natural Resources Defense Council, Inc.Supreme Court of the United States · 1984
  2. Quern v. JordanSupreme Court of the United States · 1979
  3. New Hampshire v. MaineSupreme Court of the United States · 2001
  4. Federal Election Commission v. AkinsSupreme Court of the United States · 1998
  5. Davis v. WakeleeSupreme Court of the United States · 1895

24 more not listed; retrieve them via the Exa API.

3Cited by2 opinions

  1. Matos Rodriguez v. Pan American Health OrganizationDistrict Court, District of Columbia · 2020
  2. Watkins v. Washington Metropolitan Area Transit AuthorityDistrict Court, District of Columbia · 2025

Showing a preview — retrieve the full document via the Exa API.

Powered by the Exa API